126 related articles for article (PubMed ID: 20214737)
1. Sarcoidosis or foreign-body granulomatous reaction during interferon treatment?
Bitetto D; Fumolo E; Fabris C; Toniutto P
Liver Int; 2010 Aug; 30(7):1083-4; author reply 1084. PubMed ID: 20214737
[No Abstract] [Full Text] [Related]
2. A levitating tattoo in a hepatitis C patient on treatment.
Atluri D; Iduru S; Veluru C; Mullen K
Liver Int; 2010 Apr; 30(4):583-4. PubMed ID: 20015152
[No Abstract] [Full Text] [Related]
3. Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases.
Descamps V; Landry J; Francès C; Marinho E; Ratziu V; Chosidow O
Dermatology; 2008; 217(1):81-4. PubMed ID: 18446029
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
5. [Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction].
Waltschew A
Pathologe; 2016 Mar; 37(2):184-6. PubMed ID: 26769217
[TBL] [Abstract][Full Text] [Related]
6. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
Bruch-Gerharz D; Reifenberger J
Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
[No Abstract] [Full Text] [Related]
7. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
López V; Molina I; Monteagudo C; Jordá E
Int J Dermatol; 2011 Mar; 50(3):287-91. PubMed ID: 21342161
[TBL] [Abstract][Full Text] [Related]
8. HLA typing in an IFN-alpha-induced scar sarcoidosis: possible pathogenetic and clinical implications.
Zampino MR; Corazza M; Borghi A; Marzola A; Virgili A
Acta Derm Venereol; 2009 Nov; 89(6):661-2. PubMed ID: 19997710
[No Abstract] [Full Text] [Related]
9. Bullous lesions at polyethylene glycol interferon-alpha-2a inoculation site in a hepatitis C virus-infected subject.
Montesu MA; Siddi V; Satta R; Pirodda C; Cottoni F
Acta Derm Venereol; 2007; 87(5):433-4. PubMed ID: 17721655
[No Abstract] [Full Text] [Related]
10. Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies.
Fischer J; Metzler G; Schaller M
Arch Dermatol; 2007 Apr; 143(4):507-10. PubMed ID: 17438184
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
Honsová E; Sticová E; Sperl J
Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
[TBL] [Abstract][Full Text] [Related]
12. Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b.
Neglia V; Sookoian S; Herrera M; Abeldaño A; Kien MC; Chouela E; Frider B
J Cutan Med Surg; 2001; 5(5):406-8. PubMed ID: 11915769
[TBL] [Abstract][Full Text] [Related]
13. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature.
Nawras A; Alsolaiman MM; Mehboob S; Bartholomew C; Maliakkal B
Dig Dis Sci; 2002 Jul; 47(7):1627-31. PubMed ID: 12141827
[TBL] [Abstract][Full Text] [Related]
14. Skin necrosis after injection of PEG-interferon alpha2b in an HCV-infected patient.
Sparsa A; Loustaud-Ratti V; Alain S; Liozon E; Bédane C; Vidal E
Acta Derm Venereol; 2004; 84(5):415-6. PubMed ID: 15503367
[No Abstract] [Full Text] [Related]
15. Interferon induced sarcoidosis with cutaneous involvement along lines of venous drainage in a former intravenous drug user.
Shuja F; Kavoussi SC; Mir MR; Jogi RP; Rosen T
Dermatol Online J; 2009 Dec; 15(12):4. PubMed ID: 20040254
[No Abstract] [Full Text] [Related]
16. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
Papaioannides D; Fotinou M; Korantzopoulos P; Latsi P; Sinapidis D; Akritidis N; Orphanidou D
Med Sci Monit; 2004 Jan; 10(1):CS5-7. PubMed ID: 14704637
[TBL] [Abstract][Full Text] [Related]
17. Systemic sarcoidosis presenting in a tattooed man undergoing treatment for hepatitis C.
Perera GK; Calonje E
Clin Exp Dermatol; 2006 May; 31(3):387-9. PubMed ID: 16681584
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced thyroid dysfunction--not always transient.
Wong VW; Cheng AY; Chan HL
J Gastroenterol Hepatol; 2009 Jun; 24(6):938-40. PubMed ID: 19638076
[No Abstract] [Full Text] [Related]
19. What caused this lingual hyperpigmentation in a patient with chronic hepatitis C?
Radha Krishna Y; Itha S
Liver Int; 2010 Mar; 30(3):416. PubMed ID: 19422481
[No Abstract] [Full Text] [Related]
20. Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin.
Guilabert A; Bosch X; Julià M; Iranzo P; Mascaró JM
Br J Dermatol; 2005 Feb; 152(2):377-9. PubMed ID: 15727663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
